Trials / Completed
CompletedNCT00389740
A Comparison Study With Alendronate and Raloxifene in Postmenopausal Women With Osteoporosis (0217-189)
A Randomized, Double-Blind, Double-Dummy, Parallel-Group, Multicenter Study to Evaluate and Compare the Effects of Alendronate and Raloxifene on Bone Mineral Density in Postmenopausal Women With Osteoporosis
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 400 (actual)
- Sponsor
- Organon and Co · Industry
- Sex
- Female
- Age
- 40 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to compare how well alendronate and raloxifene increase the bone density in women who have osteoporosis and have experienced menopause.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MK0217, /Duration of Treatment : 12 Months | |
| DRUG | Comparator : raloxifene hydrochloride /Duration of Treatment : 12 Months |
Timeline
- Start date
- 2001-04-02
- Primary completion
- 2003-01-16
- Completion
- 2003-01-16
- First posted
- 2006-10-19
- Last updated
- 2024-08-14
Source: ClinicalTrials.gov record NCT00389740. Inclusion in this directory is not an endorsement.